COURAGE CLINICAL OUTCOMES UTILIZING REVASCULARIZATION & AGGRESSIVE DRUG EVAL
COURAGE CLINICAL OUTCOMES UTILIZING REVASCULARIZATION & AGGRESSIVE DRUG EVAL
批准号:
7376566
负责人:
ERIC R BATES
金额:
$3.78万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-05 至 2007-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Coronary artery disease is a process that results in "hardening the arteries." When the arteries that supply blood and oxygen to your heart muscle become clogged or narrowed, a heart attack may result, or you may feel chest discomfort (angina) sometimes even while resting. The best treatment for patients like yourself with coronary artery disease is unclear. There are three kinds of approaches: treatment with medicines, coronary artery bypass (open heart) surgery, and balloon angioplasty. Balloon angioplasty has been used safely in patients like yourself for over 15 years. It is a technique for widening the narrowed arteries in the heart by either inflating a small balloon placed in the narrowed area or using a special device (rotoblator) to burrow through, or shave (directional atherectomy), plaques of calcium from the narrowed areas. Sometimes a small expandable stainless steel mesh tube (stent) is placed in the artery to assist it in remaining open. It has not been proven in patients like yourself whether those who have balloon angioplasty live longer, have fewer heart attacks, or have a better quality of life than those who only have medicine. The American Heart Association has developed guidelines for intensive treatment of patients with coronary artery disease with medicines. These medicines include aspirin, drugs that decrease the work of the heart (beta-blockers), drugs that relax the coronary arteries so that more blood can flow through the narrowed artery (nitroglycerin, calcium channel blockers), drugs that lower blood pressure, drugs that decrease cholesterol and blood fats, and for women, an estrogen supplement. In addition to medicines, these guidelines include recommendations to pay attention to diet and exercise and to stop smoking. The purpose of this study is to determine whether in patients like yourself, adding balloon angioplasty to the medical therapy suggested by the American Heart Association will result in fewer deaths and heart attacks or a better quality of life than treatment with medical therapy alone. All patients receive maximum medical therapy and half of the patients will receive a percutaneous procedure (PCI). Patients will be followed for 3-5 years to follow their cardiac symptoms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BARI-2D - BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES
-
批准号:7603774
-
项目类别:
-
资助金额:$0.34万
-
财政年份:2007
-
负责人:ERIC R BATES
-
依托单位:
COURAGE CLINICAL OUTCOMES UTILIZING REVASCULARIZATION & AGGRESSIVE DRUG EVAL
-
批准号:7603744
-
项目类别:
-
资助金额:$0.97万
-
财政年份:2007
-
负责人:ERIC R BATES
-
依托单位:
BARI-2D BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES
-
批准号:7376610
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2006
-
负责人:ERIC R BATES
-
依托单位:
COURAGE CLINICAL OUTCOMES UTILIZING REVASCULARIZATION & AGGRESSIVE DRUG EVAL
-
批准号:7199895
-
项目类别:
-
资助金额:$3.5万
-
财政年份:2005
-
负责人:ERIC R BATES
-
依托单位:
BARI-2D BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES
-
批准号:7199933
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2005
-
负责人:ERIC R BATES
-
依托单位:
COURAGE Clinical Outcomes Utilizing Revascularization & Aggressive Drug Eval.
-
批准号:7039861
-
项目类别:
-
资助金额:$2.29万
-
财政年份:2004
-
负责人:ERIC R BATES
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
-
批准号:82371144
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:汪雪玲
-
依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
-
批准号:82371317
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:万杰清
-
依托单位:
KLK10调控胶质—血管耦合与对话促缺血性卒中后血脑屏障修复的机制
-
批准号:82371465
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李龙宣
-
依托单位:
骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
-
批准号:82370820
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王天歌
-
依托单位:
气体信号分子硫化氢对颈动脉窦压力反射感受器的调节作用及机制
-
批准号:81100181
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2011
-
负责人:廖莹
-
依托单位:
精神分裂症特异微小RNA的筛选、鉴定及其靶向调控功能研究
-
批准号:81000583
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:徐勇
-
依托单位:
人脐血间充质干细胞成骨潜能亚群的特异性分子标志
-
批准号:30800232
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2008
-
负责人:刘广鹏
-
依托单位: